Medical News

Outcomes of HA for Femoral Neck Fractures in Patients with Parkinson’s Disease

A recent retrospective cohort study evaluated the outcomes of femoral neck fractures (FNF) treated with hemiarthroplasty (HA) in patients with...

30 Apr, 2019

 
Email this page
Novel Treatment Algorithm for Proximal Humerus Fractures

A recent prospective study analyzed the feasibility and clinical outcomes of an evidence-based algorithm to treat proximal humerus fractures (PHF)....

25 Apr, 2019

 
Email this page
Incidence of Malignancies with Tocilizumab versus Other Biologic Drugs in Newly Treated RA Patients

A recent multi-database cohort study examined the rate of incident malignancies excluding non-melanoma skin cancer (NMSC) in patients with...

09 Apr, 2019

 
Email this page
Weight Adjusted BMC, A Better Option for Osteoporosis Diagnosis in Individuals at Any Age

Osteoporosis diagnosis using areal bone mineral density (aBMD) may lead to misdiagnosis in patients with small bones and diagnosis may be missed in...

01 Apr, 2019

 
Email this page

Key Trials

Effect of Teriparatide Treatment on Mesenchymal Stromal Cells Functionality in Postmenopausal Osteoporotic Women with Atypical Femoral Fractures

Prevalence of atypical femoral fractures (AFF) induced by long-term treatment with bisphosphonates, ranges between 3.22 and 113.1 cases per 100,000...

Adalimumab Treatment Demonstrates Long-term Safety Profile in Japanese Patients with RA

This study determined the incidence of adverse drug reactions (ADRs) and factors associated with the safety and efficacy of adalimumab in Japanese...

Continuing versus Withdrawing Adalimumab Therapy in Patients with Active Non-radiographic Axial Spondyloarthritis

ABILITY-3 study is a randomized controlled trial evaluating the safety and efficacy of continuing versus withdrawing adalimumab therapy in patients...

Post-Hip Fracture, Alendronate Treatment is Associated with Reduced Cardiovascular Risk

This is the first large contemporary analysis of real-world clinical practice that compared the risk of cardiovascular events among hip fracture...

Patient Education

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is an inflammatory disease caused when the immune system attacks body’s own tissues. This leaflet gives an overvie...

Food Rich in Calcium and Vitamin D

Eating foods rich in calcium and vitamin D may help prevent bones from becoming weak and less likely to fracture.  This article gives a list of food...

Calcium – Vitamin D Recommended Dietary Allowance

Calcium and vitamin D are two essential nutrients long known for their roles in maintaining bone health. This article gives comprehensive recommended...

Our Publications

Risofos Kit (Risedronate, Calcium citrate malate, Vitamin D3) – Data Sheet

This datasheet covers the rationale for Risofos kit formulation, its composition, dosage and administration information.

Calcinase (calcitonin) – Monograph

This monograph covers various aspects of osteoporosis management and pharmacology, clinical efficacy & safety of calcitonin in treatment of...

Imutrex (methotrexate) – Getting to the Heart of Rheumatoid Arthritis Abstracts Booklet

This publication features efficacy & safety studies of methotrexate in management of rheumatoid arthritis.

Risofos 150 (Risedronate) – Monograph

Risendronate 150 mg is used for the management of osteoporosis. This monograph provides information on its basic pharmacology, clinical efficacy...

Slide Library

Recommendations for Up & Downscaling of Methotrexate Dose in Rheumatoid Arthritis

Methotrexate (MTX) is the first-line treatment for early and clearly defined rheumatoid arthritis (RA). This presentation summarizes the...

 
Email this page
Musculoskeletal Manifestations of Ulcerative Colitis

This slide set covers the common musculoskeletal manifestations of inflammatory bowel diseases (IBD) and its management. The spectrum of these...

 
Email this page
ACR 2015 Recommendations for the use of Non-biologic & Biologic DMARDs in RA

Majority of patients with a confirmed diagnosis of RA use nonbiologic DMARDs. The rate of biologic DMARDs use in RA treatment is also rising rapidly...

 
Email this page
Myositis Specific and Associated Antibodies

Idiopathic inflammatory myopathies (IIMs) constitute a heterogeneous group of chronic systemic autoimmune diseases with high morbidity and...

 
Email this page

Poll

Which of the following bisphosphonate is preferred as first line treatment of osteoporosis-
Alendronate
75% (3 votes)
Risedronate
0% (0 votes)
Ibandronate
0% (0 votes)
Zoledronic acid
25% (1 vote)
Total votes: 4